Research at Biogen Source: Biogen Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows.  The Japanese drugmaker and its partner Biogen last week released an additional analysis of clinical trials of the monoclonal antibody drug, which is also known as lecanemab. Alzheimer’s disease continued toContinue Reading

The Conversation

As the French and Chinese presidents, Emmanuel Macron and Xi Jinping, were discussing the need for more constructive international engagement to end the war in Ukraine, it emerged this week that Ukraine, too, was open to reconsidering its options. A top adviser to Ukraine’s president, Volodymyr Zelensky, noted that KyivContinue Reading